Porton Pharma Solutions Ltd.

SZSE:300363 Stock Report

Market Cap: CN¥6.3b

Porton Pharma Solutions Future Growth

Future criteria checks 4/6

Porton Pharma Solutions is forecast to grow earnings and revenue by 109.8% and 19.3% per annum respectively. EPS is expected to grow by 109.7% per annum. Return on equity is forecast to be 4.1% in 3 years.

Key information

109.8%

Earnings growth rate

109.7%

EPS growth rate

Pharmaceuticals earnings growth19.3%
Revenue growth rate19.3%
Future return on equity4.1%
Analyst coverage

Low

Last updated20 Sep 2024

Recent future growth updates

Recent updates

Is Porton Pharma Solutions (SZSE:300363) Weighed On By Its Debt Load?

Jun 26
Is Porton Pharma Solutions (SZSE:300363) Weighed On By Its Debt Load?

Analysts Just Shaved Their Porton Pharma Solutions Ltd. (SZSE:300363) Forecasts Dramatically

May 02
Analysts Just Shaved Their Porton Pharma Solutions Ltd. (SZSE:300363) Forecasts Dramatically

Does Porton Pharma Solutions (SZSE:300363) Have A Healthy Balance Sheet?

Mar 26
Does Porton Pharma Solutions (SZSE:300363) Have A Healthy Balance Sheet?

Porton Pharma Solutions Ltd.'s (SZSE:300363) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Mar 04
Porton Pharma Solutions Ltd.'s (SZSE:300363) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Earnings and Revenue Growth Forecasts

SZSE:300363 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,184300N/A8182
12/31/20253,923186N/A5424
12/31/20243,032-188N/A6473
6/30/20242,681-314-879-15N/A
3/31/20242,966-122-614355N/A
12/31/20233,667267-501629N/A
9/30/20234,854880-151,199N/A
6/30/20235,4601,2031,7092,876N/A
3/31/20236,9701,9281,3592,593N/A
1/1/20237,0352,0051,3912,564N/A
9/30/20226,2931,7411,3252,533N/A
6/30/20225,7631,522-299850N/A
3/31/20224,005818-103779N/A
1/1/20223,105524-297480N/A
9/30/20212,614446-146415N/A
6/30/20212,40240814487N/A
3/31/20212,224364-46439N/A
12/31/20202,072324110504N/A
9/30/20201,958289177524N/A
6/30/20201,852251189400N/A
3/31/20201,689217240441N/A
12/31/20191,551186176351N/A
9/30/20191,430163148290N/A
6/30/20191,299159182337N/A
3/31/20191,22511940174N/A
12/31/20181,18512425194N/A
9/30/20181,1911346163N/A
6/30/20181,10179-182-20N/A
3/31/20181,03973N/A170N/A
12/31/20171,184107N/A291N/A
9/30/20171,242121N/A276N/A
6/30/20171,307138N/A458N/A
3/31/20171,399182N/A398N/A
12/31/20161,327171N/A285N/A
9/30/20161,194148N/A183N/A
6/30/20161,097148N/A74N/A
3/31/20161,029125N/A-14N/A
12/31/20151,021110N/A112N/A
9/30/20151,155142N/A349N/A
6/30/20151,156138N/A316N/A
3/31/20151,072127N/A304N/A
12/31/2014987125N/A122N/A
9/30/201471971N/A-90N/A
6/30/201473988N/A-9N/A
3/31/201472390N/A42N/A
12/31/2013734100N/A114N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300363 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).

Earnings vs Market: 300363 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 300363 is expected to become profitable in the next 3 years.

Revenue vs Market: 300363's revenue (19.3% per year) is forecast to grow faster than the CN market (13.1% per year).

High Growth Revenue: 300363's revenue (19.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300363's Return on Equity is forecast to be low in 3 years time (4.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y